Molinelli C, Bruzzone M, Blondeaux E, Ruelle T, et al. The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study. Eur J Cancer 2024;213:115113.
PMID: 39536433